Analytical Data
-
基因名
C21orf33
- Application
-
别名
Protein GT335Protein KNP-I
-
种属
Human
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P30042
-
表达区间
43-268aa
-
分子量
50.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C21orf33, located on chromosome 21, has garnered interest in the field of molecular biology due to its potential roles in various physiological and pathological processes. Initially identified as a gene of unknown function, C21orf33 has been associated with several conditions, including developmental disorders and cancer. Research indicates that C21orf33 may play a role in cellular signaling pathways, influencing cell proliferation and differentiation. The reconstitution of the C21orf33 protein allows for detailed studies of its structural and functional characteristics, facilitating the exploration of its interactions with other proteins and cellular components. Additionally, recombinant C21orf33 protein is valuable for investigating its expression patterns across different tissues, aiding in the understanding of its biological significance. Studies utilizing this protein have the potential to unveil new insights into its mechanisms of action and contributions to disease pathology, with implications for therapeutic developments targeting related disorders. As a result, C21orf33 recombinant protein research is a promising avenue not only for elucidating the protein's function but also for exploring its potential as a biomarker or therapeutic target in various diseases.
